For years, the media environment has been saturated with these terms meant to imply alcohol consumption conveys health benefits. But do they stand up to honest scrutiny? As the industry follows a well-established playbook by pouring billions into bought-and-paid-for inquiry and decision-makers ignore or even suppress research that contradicts those findings, the public’s questions mount.
The following Frequently Asked Questions provide an overview of when, why, and how Big Alcohol has seeded and propagated the myths of “Healthy Drinking”.
In January 2026, the USDA released its 2025-2030 Dietary Guidelines for Americans, which, among other things, contains the official guidance around alcohol risk and consumption limits. The advisory document stated simply that one should “[c]onsume less alcohol for your health.”
This advice represented a double-edged sword for public health advocates. On the one hand, the one point it delivered has been a central contention of alcohol harm advocates for years: there is no safe level of alcohol consumption. On the other hand, it erased an entire page of context and education, including warnings about the links to cancer.
This came after a contentious period of consideration in which the U.S. Department of Health and Human Services (HHS) delayed, then cancelled the publication of a report detailing the myriad health risks from alcohol consumption. For those who had been following industry lobbying efforts and the government’s intertwining and sometimes conflicting narratives around the physical harms of alcohol, the action was not so much shocking as inevitable. The suppressed report, called simply the Alcohol Intake & Health Study, ran counter to a lucrative industry narrative, namely that alcohol has health benefits.
Yet by trying to erase the report from existence, the industry reignited the discussion over whether alcohol can be safe to consume at all. Is there really any such quantity of “moderate” drinking that produces health benefits? In past years, that narrative had been laundered by 60 Minutes, trumpeted as the “French Paradox,” and held forth as the reason for an aborted, industry-funded, NIAAA-run trial.
The only problem? It’s not true. Year after year, the evidence mounts that there is no healthy level of drinking. And so we get the excessively vague 2025-2030 Dietary Guidelines, caught between the preponderance of evidence that alcohol simply cannot be consumed risk-free, and industry pressures to endorse the idea of drinking to live longer.
That idea of “healthy drinking” is the holy grail for the alcohol industry. From Big Alcohol’s standpoint, the only thing more financially lucrative than convincing people not to quit is talking to people who are worried about their health to start drinking. The origin of the myth is buried in a long history of bad science distorted by industry; its effects are to create an endless discussion that mires U.S. alcohol policy in antiquated rhetoric, far behind the cutting edge of epidemiological research.
The below FAQ gives an overview of healthy drinking as a concept: where it originated, what are its flaws, and what are the consequences from leaving it unchallenged?
Image by Val.Pearl via Flickr, used under CC license.
Unambiguously, alcohol causes or influences numerous physical and social harms, including a number of preventable causes of death.
The CDC’s Alcohol-Related Disease Impact system tracks 57 different harmful outcomes associated with alcohol use, while a growing body of research describes alcohol’s many harms to others.
Of the harms to the drinker, some of them are physiological, including cancer, liver failure, and neurological damage. These usually (but not exclusively) arise from long-term drinking. Other harms are largely attributable to acute overconsumption—often but not exclusively binge drinking. Binge drinking is strongly associated with motor vehicle crashes, homicide, and suicide, and these risks are overrepresented in young drinkers. Binge drinking also increase vulnerability to infection and overdose, risks that may have been exacerbated in recent years as both pathogens and a dangerous drug supply have run rampant.
For many of these morbidities and mortalities, the risks start at the first sip, and rise from there.
The initial concept of healthy drinking came from a 1974 study by Kaiser Permanente’s Arthur Klatsky, MD. Dr. Klatsky looked at the medical records of 464 patients from within the hospital system, finding that those who reported not drinking were more likely to suffer a heart attack. This was elaborated on by British epidemiologists in 1981, who analyzed longitudinal data and found that nondrinkers and heavy drinkers were more likely to experience early mortality than those who drank less. This pattern—elevated with non-drinkers, dipping for the lower levels of drinkers, and rising again with heavy drinkers—became known as a the “j-shaped curve.”
Before the 1980s were through, major studies were challenging the “j-shaped curve” pattern of alcohol risk. But before the academic discussion could play out (though to some degree, it is still playing out), publicists for the alcohol industry fed noted television news program 60 Minutes a piece on the “French Paradox.”
According to the 1991 serial, the French were exceptionally long-lived and less prone to cardiovascular disease despite eating high-fat, high-cholesterol diets.* The reason, according to the report, was red wine consumption.
The only problem? It wasn’t true. Indeed, the purportedly healthy French relationship with alcohol has itself been questioned by… the French, who have launched national initiatives to relieve the burden of alcohol harm.
* Ironically, this debate would hinge around a parallel industry conspiracy (literally) to distort science. Along with Big Alcohol’s ongoing misrepresentation of risk research, the sugar industry had, starting in the late 1960s, worked to lay the blame for cardiovascular and metabolic diet risk entirely on the shoulders of fats and cholesterol. Only in the 2000s did watchdogs uncover the decades-long web of funding to pliable scientists, generating sloppy science that let low-fat, high-sugar foods dominate the marketplace, to the detriment of millions worldwide.
Industry proponents have long anchored their arguments in favor of a j-shaped risk curve on a particular kind of methodology: longitudinal population-based observational studies. These studies are characterized by having a large number of participants assessed for numerous health outcomes at once, over a long period of time.
There are major advantages for this kind of research, and it’s clear why some would be drawn to them. They capture a large amount of data, and create “sandboxes” for researchers to dig through for interesting relationships. Yet these strengths also make findings vulnerable to overlooking confounders and modifiers. These overlooked variables are precisely what makes the “j-shaped curve” a dubious finding.

Reviewing the studies which purport to find a protective effect from alcohol consumption, three consistent flaws emerge.
When approaching these same old data sets with less credulousness, researchers have found the exact same populations show no j-shaped curve around alcohol consumption. By factoring in self-evident confounders including history of dangerous drinking and socioeconomic status, the protective effect of alcohol disappears. Instead, the straightforward (but not 60 Minutes-worthy) connection between any alcohol use and elevated risks of harm and death are once again stark.
The government’s suppressed Alcohol Intake & Health Study sidesteps the traps of these large but imprecise data sets entirely. Instead of using the “top-down” longitudinal data, the authors approach alcohol harm from a bottom-up perspective. That is, instead of casting a dragnet for any causes of death, researchers can start with as many of the known harms known from alcohol consumption as possible, and trace how often these occur in the population as consumption increases. This approach likewise suggests no notable survival at lower levels of consumption compared to non-drinkers; instead, as the amount of alcohol consumed rises, so does the morbidity and mortality.
Still other studies use what’s called a “Mendelian randomization” approach to try and tease out influences that come from genetic predisposition. Not only does this adapt to innate biological resistance or susceptibility to alcohol specifically, it can give hints that other biological predispositions may be influencing both deaths and decisions to consume alcohol. These studies have yet to come up with a set of “smoking gun” phenotypes, but they have turned the study of the j-shaped curve from an endless back-and-forth between industry-endorsed methodology and its detractors, and into questions about how biological and psychological risk and protective factors cluster.
In January 2025, the normally unremarkable (to most) process of constructing the USDA Dietary Guidelines—which, for decades, included advice around alcohol risk—was upended by a prominent rhetorical fight. On the one hand, a panel of scientists at the National Academies of Science, Engineering and Medicine (NASEM) had released a report using the same flawed, industry-championed longitudinal all-cause mortality approach to argue that drinking alcohol saves lives. Despite the clear presence of industry funding and influence on the process, the results were championed by Big Alcohol as confirming that the USDA guidelines must state that low-level drinking can be healthy.
On the other hand, a parallel panel convened by the Substance Abuse and Mental Health Services Administration (SAMHSA) used the “bottom up” approach to assess harm, as well as looking at areas such as underage drinking that the NASEM group ignored. Their report documented no safe levels of consumption. This would become the notorious Alcohol Intake & Health study. But between the release of NASEM and SAMHSA reports, the Office of the Surgeon General unexpectedly released a third report on alcohol and health, highlighting the underrecognized cancer risks and calling for increased awareness of them.
The stakes are a single paragraph in the USDA guidelines: should U.S. residents be advised that there is a safe level of drinking, or should they be advised that all drinking has risks? As of the last update of this page, the USDA had not made its determination, but seems inclined to abandon its responsibility on the subject entirely, cutting the entire alcohol consumption section down to a single line urging moderation.
Under Sec. Kennedy and the current administration, HHS has asserted that it will adhere to “gold standard” research. More than any other methodology, randomized controlled trials (RCTs) are held up as supporting this kind of ideal.
Laying aside the fact that the “gold standard” for medical evidence is far more nuanced than some are willing to accept, the industry already bent over backwards to have an RCT custom-designed to deliver the results it wanted. In 2018, the National Institutes of Alcohol Abuse and Alcoholism received over $67 million from Big Alcohol for the MACH 15 trial. The project planned to administer daily alcohol to participants as if it were a medication, and compare their long-term health to that of a group not receiving the alcohol. As public outrage mounted, it became clear the donation had been solicited by the proposed principal investigator before the research plan was in place, then funneled through a foundation to obfuscate the source. The trial was cancelled.
Aside from the blatant corruption in its design and staffing, the process revealed flaws in embracing RCTs simply on face value. This RCT carefully excluded a large number of potential participants who, it stood to reason, might suffer adverse consequences from additional exposure to alcohol. It also restricted the time frame in which it evaluated outcomes, making only short-term causes of harm and death measurable by the study. It could not have been more perfectly engineered to miss the myriad subtler routes of harm.
To date, nobody has proposed a follow-up at scale, and as evidence mounts of linear accumulation of risk, it becomes harder to do so. No trial should be able to get approved if the treatment in question is already known to result in poorer health.

The industry won’t readily let go of the potential windfall from manufacturing the “healthy drinking” narrative and the j-shaped curve. But even despite the suppression and distortion of emerging evidence, the public perception of alcohol as unsafe has continued to grow—though so too has alcohol’s toll on our friends and neighbors.
The public deliberations around the USDA Dietary Guidelines have ended for this five-year review period, and the final product glosses over alcohol risks. But other, thorough, evidence-based sets of recommendation exist (such as these, from the U.S. Alcohol Policy Alliance), and there remain many opportunities to promote them and grow public understanding of harm and increase individuals’ control over their own health, including:
Pushing for more effective on-bottle warning labels, in line with the Surgeon General’s suggestion.
Advocating for protective policies that both promote treatment and reduce consumption, including Charge For Harm tax policies and defending state stores.
Calling out deceptive marketing, including pinkwashing, healthy drinking, fitness–alcohol crossmarketing, and crossover products.
Uniting with community members, researchers, and advocates to insist on prevention, protection, and evidence-based policy.
For more information on how to get involved, contact advocacy@alcoholjustice.org.